ResearcherShizuoka Cancer CenterNo recent work listed
Fumihiro Terasaki
Matched on ORCID iD 0000-0002-1562-3265; OpenAlex author ID A5055948124. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: 1 paper · 2021: 1 paper
Papers 3
- The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13304-020-00792-9↗
- Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. Co-author DOI 10.1007/s00423-020-01874-3↗
- Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00423-019-01749-2↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Teiichi Sugiura · 2 shared papers, 2020–2021 · strength 0.26
- Paper The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal… DOI 10.1007/s13304-020-00792-9↗
- Paper Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. DOI 10.1007/s00423-020-01874-3↗
- Ryo Ashida · 2 shared papers, 2020–2021 · strength 0.26
- Paper The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal… DOI 10.1007/s13304-020-00792-9↗
- Paper Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. DOI 10.1007/s00423-020-01874-3↗
- Takaaki Ito · 2 shared papers, 2020–2021 · strength 0.26
- Paper The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal… DOI 10.1007/s13304-020-00792-9↗
- Paper Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. DOI 10.1007/s00423-020-01874-3↗
- Katsuhiko Uesaka · 2 shared papers, 2020–2021 · strength 0.26
- Paper The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal… DOI 10.1007/s13304-020-00792-9↗
- Paper Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. DOI 10.1007/s00423-020-01874-3↗
- Katsuhisa Ohgi · 2 shared papers, 2020–2021 · strength 0.26
- Paper The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal… DOI 10.1007/s13304-020-00792-9↗
- Paper Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. DOI 10.1007/s00423-020-01874-3↗
- Yukiyasu Okamura · 2 shared papers, 2020–2021 · strength 0.26
- Paper The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal… DOI 10.1007/s13304-020-00792-9↗
- Paper Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus. DOI 10.1007/s00423-020-01874-3↗
- Yuji Kaneoka · 1 shared paper, 2019 · strength 0.11
- Yasuyuki Fukami · 1 shared paper, 2019 · strength 0.11
- Atsuyuki Maeda · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.